Literature DB >> 19617888

Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry.

Josep Villanueva1, Arpi Nazarian, Kevin Lawlor, Paul Tempst.   

Abstract

Measuring enzymatic activities in biological fluids is a form of activity-based proteomics and may be utilized as a means of developing disease biomarkers. Activity-based assays allow amplification of output signals, thus potentially visualizing low-abundant enzymes on a virtually transparent whole-proteome background. The protocol presented here describes a semiquantitative in vitro assay of proteolytic activities in complex proteomes by monitoring breakdown of designer peptide substrates using robotic extraction and a matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometric readout. Relative quantitation of the peptide metabolites is carried out by comparison with spiked internal standards, followed by statistical analysis of the resulting mini-peptidome. Partial automation provides reproducibility and throughput essential for comparing large sample sets. The approach may be used for diagnostic or predictive purposes and it enables profiling of 96 samples in 30 h. It could be tailored to many diagnostic and pharmaco-dynamic purposes as a readout of catalytic and metabolic activities in body fluids or tissues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617888      PMCID: PMC2760592          DOI: 10.1038/nprot.2009.88

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  13 in total

Review 1.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

2.  Differential exoprotease activities confer tumor-specific serum peptidome patterns.

Authors:  Josep Villanueva; David R Shaffer; John Philip; Carlos A Chaparro; Hediye Erdjument-Bromage; Adam B Olshen; Martin Fleisher; Hans Lilja; Edi Brogi; Jeff Boyd; Marta Sanchez-Carbayo; Eric C Holland; Carlos Cordon-Cardo; Howard I Scher; Paul Tempst
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

3.  Automated serum peptide profiling.

Authors:  Josep Villanueva; Kevin Lawlor; Ricardo Toledo-Crow; Paul Tempst
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Data analysis of assorted serum peptidome profiles.

Authors:  Josep Villanueva; John Philip; Lin DeNoyer; Paul Tempst
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 5.  Proteases: multifunctional enzymes in life and disease.

Authors:  Carlos López-Otín; Judith S Bond
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

6.  Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age.

Authors:  Josep Villanueva; Andrew J Martorella; Kevin Lawlor; John Philip; Martin Fleisher; Richard J Robbins; Paul Tempst
Journal:  Mol Cell Proteomics       Date:  2006-08-08       Impact factor: 5.911

7.  Aminopeptidase activities in breast cancer tissue.

Authors:  J M Martínez; I Prieto; M J Ramírez; C Cueva; F Alba; M Ramírez
Journal:  Clin Chem       Date:  1999-10       Impact factor: 8.327

Review 8.  Emerging roles of proteases in tumour suppression.

Authors:  Carlos López-Otín; Lynn M Matrisian
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

9.  Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry.

Authors:  Josep Villanueva; John Philip; David Entenberg; Carlos A Chaparro; Meena K Tanwar; Eric C Holland; Paul Tempst
Journal:  Anal Chem       Date:  2004-03-15       Impact factor: 6.986

10.  Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII.

Authors:  Barbara Leiting; KellyAnn D Pryor; Joseph K Wu; Frank Marsilio; Reshma A Patel; Charles S Craik; Jonathan A Ellman; Richard T Cummings; Nancy A Thornberry
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

View more
  11 in total

1.  Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling.

Authors:  Simone Nicolardi; Magnus Palmblad; Hans Dalebout; Marco Bladergroen; Rob A E M Tollenaar; André M Deelder; Yuri E M van der Burgt
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-12       Impact factor: 3.109

Review 2.  Profiling protease activities by dynamic proteomics workflows.

Authors:  Diana Klingler; Markus Hardt
Journal:  Proteomics       Date:  2012-01-23       Impact factor: 3.984

3.  Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics.

Authors:  Brandon Alexander Holt; Quoc D Mac; Gabriel A Kwong
Journal:  J Vis Exp       Date:  2018-07-16       Impact factor: 1.355

4.  The Use of Principal Component Analysis in MALDI-TOF MS: a Powerful Tool for Establishing a Mini-optimized Proteomic Profile.

Authors:  Changli Shao; Yaping Tian; Zhennan Dong; Jing Gao; Yanhong Gao; Xingwang Jia; Guanghong Guo; Xinyu Wen; Chaoguang Jiang; Xueji Zhang
Journal:  Am J Biomed Sci       Date:  2012

Review 5.  Targeting proteases in cardiovascular diseases by mass spectrometry-based proteomics.

Authors:  Diana Klingler; Markus Hardt
Journal:  Circ Cardiovasc Genet       Date:  2012-04-01

6.  Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.

Authors:  Arpi Nazarian; Kevin Lawlor; San San Yi; John Philip; Mousumi Ghosh; Mariana Yaneva; Josep Villanueva; Alan Saghatelian; Melissa Assel; Andrew J Vickers; James A Eastham; Howard I Scher; Brett S Carver; Hans Lilja; Paul Tempst
Journal:  Mol Cell Proteomics       Date:  2014-07-23       Impact factor: 5.911

7.  Analysis of peptides by denaturing ultrafiltration and LC-MALDI-TOF-MS.

Authors:  Yanming An; Radoslav Goldman
Journal:  Methods Mol Biol       Date:  2013

8.  Serum metabolomics in a Helicobacter hepaticus mouse model of inflammatory bowel disease reveal important changes in the microbiome, serum peptides, and intermediary metabolism.

Authors:  Kun Lu; Charles G Knutson; John S Wishnok; James G Fox; Steven R Tannenbaum
Journal:  J Proteome Res       Date:  2012-09-27       Impact factor: 4.466

9.  Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability.

Authors:  Peter Findeisen; Victor Costina; Diego Yepes; Ralf Hofheinz; Michael Neumaier
Journal:  J Exp Clin Cancer Res       Date:  2012-06-08

10.  A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma.

Authors:  Koji Ueda; Naomi Saichi; Sachiko Takami; Daechun Kang; Atsuhiko Toyama; Yataro Daigo; Nobuhisa Ishikawa; Nobuoki Kohno; Kenji Tamura; Taro Shuin; Masato Nakayama; Taka-Aki Sato; Yusuke Nakamura; Hidewaki Nakagawa
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.